Waardenburg syndrome type 4 (WS4) is a rare neural crest disorder defined by the combination of Waardenburg syndrome (sensorineural hearing loss and pigmentation defects) and Hirschsprung disease (intestinal aganglionosis). Three genes are known to be involved in this syndrome, that is, EDN3 (endothelin-3), EDNRB (endothelin receptor type B), and SOX10. However, 15-35% of WS4 remains unexplained at the molecular level, suggesting that other genes could be involved and/or that mutations within known genes may have escaped previous screenings. Here, we searched for deletions within recently identified SOX10 regulatory sequences and describe the first characterization of a WS4 patient presenting with a large deletion encompassing three of these enhancers. Analysis of the breakpoint region suggests a complex rearrangement involving three Alu sequences that could be mediated by a FosTes/MMBIR replication mechanism. Taken together with recent reports, our results demonstrate that the disruption of highly conserved non-coding elements located within or at a long distance from the coding sequences of key genes can result in several neurocristopathies. This opens up new routes to the molecular dissection of neural crest disorders.
INTRODUCTION
Waardenburg syndrome type 4 (WS4), also referred to as ShahWaardenburg syndrome or Waardenburg-Hirschsprung disease, is a neural crest disorder characterized by the association of Waardenburg syndrome features (WS, depigmentation defects and deafness) with the absence of enteric ganglia in the distal part of the intestine (Hirschsprung disease, HD). 1, 2 Approximately, 20-30% of cases are due to homozygous or heterozygous mutations within the EDN3 (endothelin-3) or the EDNRB (endothelin receptor type B) genes, whereas approximately 45-55% result from heterozygous mutations within the gene encoding the SOX10 (Sry bOX10) transcription factor. 2 Several of the known SOX10 mutations are responsible for extended phenotypes, including peripheral and central neurological defects, and they are referred to as PCWH (peripheral demyelinating neuropathyCentral dysmyelinating leucodystrophy -WS -HD). 3 However, 15-35% of WS4 cases remain unexplained at the molecular level, suggesting that other genes could be involved and/or that mutations within the known genes or their regulatory sequences have escaped previous screenings.
Recent reports show that the disruption of highly conserved noncoding elements located within or at a long distance from the coding sequences of key genes can result in several neurocristopathies, particularly HD. 4, 5 Thus, identifying genomic alterations that affect the conserved sequences of WS4 genes might provide further insights into the molecular aetiology of this syndrome.
Recently, sequence comparison analysis has led to the identification of several evolutionarily conserved regions with putative enhancer activity around the SOX10 locus. [6] [7] [8] [9] [10] In particular, we and others identified five of these regulatory elements upstream of the human SOX10 gene (U1-5; U1 is localised 55 kb upstream of the SOX10 gene) and one downstream (D6+7) (Werner et al 9 ; Yokota et al 10 and our unpublished results). The functional relevance of each of these elements was studied in different cell lines and in zebrafish, chicken and mouse models. Most of them direct expression in several neural crest derivatives, the enteric nervous system, and melanocytes in particular. 7, 9 Here, we used semi-quantitative fluorescent multiplex PCR (QMF-PCR) to search for deletions within these elements and describe a WS4 patient presenting with a deletion encompassing three of them.
METHODS
A total of 13 patients presenting with a classical form of WS4, and 9 patients with its neurological variant (PCWH) were screened in this study. They were previously found negative for gene rearrangement and point mutation in the coding exons of SOX10 (WS4 and PCWH patients), as well as EDN3 and EDNRB (WS4 only). DNA samples were obtained for genetic testing with informed consent, according to French law. Genomic DNA was extracted from peripheral blood leucocytes using standard protocols.
QMF-PCR protocol and primers used are available within Supplementary data (Supplementary Table 1 ).
The deletion breakpoint region was amplified by long range PCR using the Expand Long Template PCR system (Roche Diagnotics, Mannheim, Germany) and sequenced using the following primers: 5¢-CCTTCCGCAAAGACTTGCT G-3¢ and 5¢-ATGGAACCTGGGAAGACACC-3¢. Alu1 and Alu2 were amplified and sequenced in both parents using the following primers: 5¢-ATG GAACCTGGGAAGACACCT-3¢ and 5¢-AAGCACAATCGGCTAAGAGG-3¢; and 5¢-ACCCAGTTTGGAGTGCAGTG-3¢ and 5¢-CCTTCCGCAAAGACTTGCTG-3¢.
Array CGH analysis was performed using the Agilent Human G3 CGH Microarray 4x180K Kit (Agilent Technologies, Massy, France) and the data were analysed with an Agilent scanner (G2565CA) and the Feature Extraction program (V10.7.3.1, Agilent technologies). Copy number variations were considered significant if defined by three or more contiguous oligonucleotides.
Paternity was verified by the use of several microsatellites from different chromosomes (the linkage-mapping set, Applied Biosystem, Carlsbad, CA, USA)
RESULTS AND DISCUSSION
QMF-PCR is known to be a sensitive method for the detection of SOX10 gene dosage anomalies. 11 The same strategy was used to screen for deletions within six regulatory sequences of interest (U1-5 and D6+7 elements, Figure 1a ) in WS4 and PCWH patients with no molecular explanation. We identified a heterozygous deletion encompassing regulatory elements U1, 2, and 3 ( Figure 1a , see regions indicated by black arrowheads) in a patient presenting with a classical WS4 phenotype.
The propositus was born at term after an uneventful pregnancy. Both healthy parents originated from the Congo. The mother already had two children, a healthy boy and a baby boy who died of an unknown cause at 1 year of age. The patient presented with major abdominal distension at birth, and he did not pass meconium. X-ray showed a dilatation of the ileum and right colon, and a clear change in calibre between the right and transverse colon. A colostomy was performed one day after birth, which was followed by ileo-rectal anastomosis using the Duhamel procedure after 3 months. Histology revealed the absence of ganglionic cells extending up to the right colon region, followed by a transition zone in the last 2 cm. The postoperative course was complicated by volvulus and occlusion, leading to a secondary ileostomy intervention and Hartman operation. Ileo-anal anastomosis was performed at 18 months of age and the associated lateral ileostomy was closed 6 months later. The patient suffered numerous episodes of acute gastroenteritis up to the age of four-and-a-half, necessitating frequent hospitalisation. He also experienced episodes of microcytic anaemia. He is now a 5-year-old boy with a normal growth curve. Neurological examination was normal.
WS was diagnosed at the age of 3 months based on the suspicion of deafness, bright blue irides, and a small white frontal forelock. A severe to profound bilateral deafness was confirmed at 8 months. MRI and a temporal bone CT scan revealed no abnormality. He was fitted with hearing aids at 21 months and showed improvement on a few frequencies using the right ear. Left ear cochlear implantation was proposed at the age of 4. The hearing thresholds with cochlear implantation reached 25 dB at all frequencies 18 months later. Speech recognition was assessed for simple sentences and he now expressed through isolated word and gesture.
Analysis of DNA samples from both parents revealed de novo occurrence of the deletion. To confirm the deletion by a second method and further delineate its extent, we next performed CGHarray in the patient and parents. This analysis revealed only one de novo copy number variation that encompassed five probes localised in the distant 5¢ region of SOX10 on chromosome 22 (Figure 1b) , Deletion of SOX10 regulatory elements N Bondurand et al confirming the results obtained using QMF-PCR. Analysis of the deletion extent identified by both techniques mapped the proximal limit between U3 and U4 sequences and the distal limit within the PICK1 gene. On the basis of these results, we chose additional sets of primers localised between regulatory sequences U3 and U4, as well as within the PICK1 gene (Figure 1a, grey arrowheads) . We thus mapped the centromeric border of the deletion to a region located 31-24 kb upstream of the SOX10 start codon, and its telomeric border between exons 1 and 4 of the PICK1 gene.
The deletion breakpoint was then amplified by long range PCR and sequenced. Comparison of the patient (Figure 2a ) and surrounding reference sequences revealed that the deletion occurred between two highly similar sequences, which were identified as Alu repeats using Repeat Masker (http://www.repeatmasker.org/). An alignment of the propositus' mutant sequence and these two Alu sequences (referred to as Alu1 for the sequence located near U3 and Alu2 for the PICK1 intronic Alu sequence) is shown in Figure 2b . These Alu sequences belonged to different subfamilies, that is AluSx for Alu1, and AluSp for Alu2. However, careful analysis of the sequence located in the central part of the patient' recombined allele revealed 38 bp that did not perfectly match any of the two Alu sequences (Figures 2a and b, boxed  regions) . Sequencing of Alu1 and Alu2 from both parents established Deletion of SOX10 regulatory elements N Bondurand et al that these variations were not inherited polymorphisms, but rather suggested the occurrence of a complex rearrangement mechanism. Attention was therefore focused on this 38 bp region. BLAST analysis revealed its 100% identity with a third Alu sequence (referred as Alu3) that uniquely occurs in the human genome. Alignment presented in Figure 2b also includes Alu3 sequence, highlighting the perfect identity with the 38 pb boxed region. Alu3 belonged to a third subfamily, AluSg, and was located on chromosome 22 at a distance of 3.25 Mb on the telomeric side of Alu2 (Figure 2c) . Overall, these observations clearly suggested that a complex rearrangement occurred between the three Alu sequences, leading to the deletion of 56.5 kb localised between Alu1 and 2 (including exons 1, 2, and 3 of PICK1 and the U1, U2, and U3 SOX10 enhancers) as well as the insertion of 38 bp of the Alu3 sequence (Figure 2c) . CGH experiments failed to detect any more complex rearrangement affecting chromosome 22. Such an event could be mediated by different mechanisms, including recombination or replication-based mechanisms. 12, 13 Of these, the FoSTeS/MMBIR model (fork stalling and template switching/ microhomology-mediated break-induced replication, FoSTeS/ MMBIR) is often proposed when the complexity of the rearrangement cannot be explained using classic recombination. 13 According to this model, the DNA replication fork stalls at a specific position during replication, at which point the lagging strand disengages from the original template, before it transfers and anneals to another replication fork by virtue of microhomology at the 3¢ end, primes and restarts DNA synthesis. This series of events can occur several times. The rearrangement characterized in the current study could be explained by a two-step FoSTeS/MMBIR mechanism mediated via the 4 bp and 13 bp microhomology found at the Alu1/Alu3 and Alu3/Alu2 breakpoints (see sequences in Figure 2b and model in Figure 3) .
The clinical outcome was in agreement with the known functions of the deleted sequences. A transgenic mouse analysis demonstrated the importance of U1 and U3 sequences during enteric nervous system development. 7, 9 Disparate results were obtained in relation to their expression profile in melanocytes. 7, 9, 10 Nevertheless, the crucial function of U1 during this process was highlighted by the description of a 16 kb deletion encompassing this regulatory element in the Sox10 Hry mouse model, which is characterized by distal intestinal aganglionosis and severe hypopigmentation. 6 The deletion described here also encompassed the U2 regulatory element, which is known to be active in oligodendrocytes. However, this element is only partly responsible for the Sox10 expression pattern in this lineage, 14 making the absence of neurological defects observed in the patient consistent with our findings. Finally, the rearrangement also led to a partial heterozygous deletion of PICK1 (protein interacting with C kinase 1), encoding a peripheral membrane protein implicated in the trafficking of multiple proteins. 15 Mouse model studies have demonstrated its crucial function in acrosome formation and synaptic plasticity. 15, 16 Homozygous missense mutations were identified in patients presenting with globozoospermia, 17 whereas polymorphisms were associated with schizophrenia in some populations but not all. 18 It seems unlikely that the heterozygous partial deletion of PICK1 contributes to the WS4 phenotype.
Alu repeats are proposed to have a number of functions in the human genome and they certainly have a major impact on the genomic architecture and are known to regulate gene expression. They are believed to contribute to about 0.4% of all human genetic diseases either via insertion events or inter-/intra-chromosomal homologous recombination, an event that can occur at very high frequencies in particular diseases. [19] [20] [21] The current study identified a novel Alu-mediated deletion that resulted in WS4. Screening of SOX10 regulatory sequences should therefore be considered in molecular diagnostic of WS4, although deletion frequency (one identified among 22 patients) does not justify its use in first intention procedures. Apart from diagnosis implications, our results strongly suggest that U1 and U3 enhancers are of major importance in the physiological regulation of SOX10 expression in human. Deletion of SOX10 regulatory elements N Bondurand et al
